Syncom Formulations (india) share price
You have to be logged in to add this to Watchlist.- ₹19.08(-0.99%)July 7, 2025 15:29:48 PM IST
- NSE
- BSE
- Vol : 1.30M (NSE + BSE)Last 20 day avg : 2.73 M
Syncom Formulations (india) is trading -0.99% lower at Rs 19.08 as compared to its last closing price. Syncom Formulations (india) has been trading in the price range of 19.36 & 18.55. Syncom Formulations (india) has given -3.55% in this year & 0.31% in the last 5 days. Syncom Formulations (india) has TTM P/E ratio 28.88 as compared to the sector P/E of 23.19.The company posted a net profit of 17.69 Crores in its last quarter.Listed peers of Syncom Formulations (india) include Ttk Health Care (-2.05%), Windlas Biotech (0.89%), Syncom Formulations (india) (-0.99%).The Mutual Fund holding in Syncom Formulations (india) was at -% in . The MF holding has - from the last quarter. The FII holding in Syncom Formulations (india) was at 0.11% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 99.64% from Rs 148.88 crore to Rs 74.57 crore, year-on-year
- The company has grown its March quarter profit by 138.97% from Rs 7.40 crore to Rs 17.69 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 19.70
- R2
- 20.14
- R3
- 20.84
- S1
- 18.56
- S2
- 17.86
- S3
- 17.42
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Ttk Health Care | Moderately Bullish | 1,329.30 | -2.05 | 1,882.09 | 26.96 | 1.8 | 0.74 | 0.17 |
| Windlas Biotech | Neutral | 908.50 | 0.89 | 1,904.29 | 31.22 | 3.72 | 0.61 | 0.46 |
| Syncom Formulations (india) | Moderately Bearish | 19.08 | -0.99 | 1,793.52 | 33.23 | 5.2 | - | - |
| Bliss Gvs Pharma | Bullish | 163.00 | 4.49 | 1,713.69 | 19.66 | 1.57 | 0.32 | 3.10 |
| Hester Biosciences | Moderately Bearish | 1,783.05 | -0.39 | 1,516.82 | 53.41 | 4.9 | 0.33 | 44.18 |
- Promoter(s) holds a high stake in the company at 50.57%
- FIIs are invested in this company
FIIs holding has decreased by 0.02 percentage points from previous quarter- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| 2024-05-17 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE312C01025
- BSE Code524470
- NSE CodeSYNCOMF
Syncom Formulations (india) is trading at 19.08 as on Mon Jul 07 2025 09:59:48. This is -0.99% lower as compared to its previous closing price of 19.27.
The market capitalization of Syncom Formulations (india) is 1793.52 Cr as on Mon Jul 07 2025 09:59:48.
The 52 wk high for Syncom Formulations (india) is 27.94 whereas the 52 wk low is 12.45
Syncom Formulations (india) can be analyzed on the following key metrics -
- TTM P/E: 28.88
- Sector P/E: 23.19
- Dividend Yield: 0.00%
- D/E ratio: 0.01
Syncom Formulations (india) reported a net profit of 49.43 Cr in 2025.